← Back to Clinical Trials
Recruiting NCT06884813

NCT06884813 Clinical Evaluation of Color-Adjusting Composite Resin Following In-Office Dental Bleaching

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06884813
Status Recruiting
Phase
Sponsor King Abdullah University Hospital
Condition Composite Resins
Study Type INTERVENTIONAL
Enrollment 120 participants
Start Date 2025-03-10
Primary Completion 2026-05-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Conventional nanohybrid multishade composite and hydrogen peroxide 40% in-Office Tooth Whitening SystemSingle shade nanohybrid composite and hydrogen peroxide 40% in-Office Tooth Whitening System

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 120 participants in total. It began in 2025-03-10 with a primary completion date of 2026-05-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

One challenge faced by dental professionals is that, unlike natural tooth structure, composite restorations do not lighten when exposed to bleaching agents. As a result, functional restorations may need replacement after bleaching to match the newly whitened teeth. However, replacing a composite restoration can lead to unnecessary removal of tooth structure, potentially weakening the tooth and increasing its susceptibility to further iatrogenic damage. This study will investigate the ability of Omnichroma restorations to shade-match tooth structure after bleaching. The null hypotheses will be: 1. Single-shade RBC will not exhibit similar shade and optical behavior to conventional RBC across all anterior restorations following bleaching. 2. Patient satisfaction regarding color blending between the restoration and tooth structure will not differ according to the type of material used. 3. Dentist satisfaction regarding color blending between the restoration and tooth structure will not differ according to the type of material used.

Eligibility Criteria

Inclusion Criteria: 1. Patients who are willing to come back for follow-up appointments. 2. Patients who are willing to sign an informed consent form. 3. Patients with well documented clinical records and have at least two anterior restorations (both Omnichroma and conventional multi-shade nanohybrid composite.) 4. Patients aged 18 years or older. 5. Patients with good oral hygiene 6. Patients with vital teeth. 7. Patients who are willing to have the restorations replaced later if necessary if there is a color mismatch after bleaching treatment. Exclusion Criteria: 1. Individuals with severe bruxism or periodontal disease. 2. Patients with non-vital teeth restored with composite fillings. 3. Patients with severe tooth discoloration. 4. Patients with fluorosis or tetracycline staining. 5. Heavy smokers. 6. Pregnant or nursing women. 7. Patients undergoing orthodontic treatment. 8. Patients with enamel or dentin deformations.

Contact & Investigator

Central Contact

Zakereyya SM Albashaireh, Ph.D

✉ albashai@just.edu.jo

📞 0791015505

Frequently Asked Questions

Who can join the NCT06884813 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Composite Resins. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06884813 currently recruiting?

Yes, NCT06884813 is actively recruiting participants. Contact the research team at albashai@just.edu.jo for enrollment information.

Where is the NCT06884813 trial being conducted?

This trial is being conducted at Irbid, Jordan.

Who is sponsoring the NCT06884813 clinical trial?

NCT06884813 is sponsored by King Abdullah University Hospital. The trial plans to enroll 120 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology